Aspira Women's Health Inc.
AWHL
$0.41
-$0.01-1.58%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.31M | 2.40M | 2.28M | 2.35M | 2.26M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.31M | 2.40M | 2.28M | 2.35M | 2.26M |
| Cost of Revenue | 922.00K | 870.00K | 719.00K | 860.00K | 902.00K |
| Gross Profit | 1.38M | 1.53M | 1.56M | 1.49M | 1.36M |
| SG&A Expenses | 2.25M | 2.67M | 3.84M | 4.43M | 4.20M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.88M | 4.21M | 5.52M | 5.78M | 6.00M |
| Operating Income | -1.58M | -1.81M | -3.24M | -3.43M | -3.74M |
| Income Before Tax | -4.89M | -2.67M | -1.85M | -1.39M | -3.55M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.89M | -2.67M | -1.85M | -1.39M | -3.55M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.89M | -2.67M | -1.85M | -1.39M | -3.55M |
| EBIT | -1.58M | -1.81M | -3.24M | -3.43M | -3.74M |
| EBITDA | -1.53M | -1.80M | -3.23M | -3.42M | -3.72M |
| EPS Basic | -0.13 | -0.08 | -0.09 | -0.08 | -0.23 |
| Normalized Basic EPS | -0.08 | -0.05 | -0.05 | -0.13 | -0.14 |
| EPS Diluted | -0.13 | -0.08 | -0.09 | -0.08 | -0.23 |
| Normalized Diluted EPS | -0.08 | -0.05 | -0.05 | -0.13 | -0.14 |
| Average Basic Shares Outstanding | 36.39M | 35.56M | 21.59M | 16.72M | 15.41M |
| Average Diluted Shares Outstanding | 36.39M | 35.56M | 21.59M | 16.72M | 15.41M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |